Profil
Jean-Marc Steens worked as Vice President & International Medical Director at ViiV Healthcare Ltd.
from 2009 to 2012.
He also worked as Chief Medical Officer at Abivax SA. He graduated from Université Catholique de Louvain.
Anciens postes connus de Jean-Marc Steens
| Sociétés | Poste | Fin |
|---|---|---|
| ABIVAX | Chief Tech/Sci/R&D Officer | 01/03/2021 |
ViiV Healthcare Ltd.
 ViiV Healthcare Ltd. Pharmaceuticals: MajorHealth Technology ViiV Healthcare Ltd. manufactures and distributes pharmaceutical products. Its medicine include Triumeq, Tivicay, Selzentry, Celesentri, Epzicom, Kivexa, Ziagen, Trizivir, Combivir, Retrovir AZT, Lexiva, Telzir, Viracept and Rescriptor. The company was founded in 2009 and is headquartered in Brentford, the United Kingdom. | Corporate Officer/Principal | 01/10/2012 |
Formation de Jean-Marc Steens
| Université Catholique de Louvain | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| ABIVAX | Health Technology |
| Entreprise privées | 1 |
|---|---|
ViiV Healthcare Ltd.
ViiV Healthcare Ltd. Pharmaceuticals: MajorHealth Technology ViiV Healthcare Ltd. manufactures and distributes pharmaceutical products. Its medicine include Triumeq, Tivicay, Selzentry, Celesentri, Epzicom, Kivexa, Ziagen, Trizivir, Combivir, Retrovir AZT, Lexiva, Telzir, Viracept and Rescriptor. The company was founded in 2009 and is headquartered in Brentford, the United Kingdom. | Health Technology |
